Page 2 - Adenocarcinoma Market Insights News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adenocarcinoma market insights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adenocarcinoma Market Insights Today - Breaking & Trending Today

Enhancing survival in advanced pancreatic cancer with ablative MR-guided radiation therapy

A study co-led by researchers at Miami Cancer Institute, part of Baptist Health South Florida, found that ablative stereotactic magnetic resonance (MR)-guided adaptive radiation therapy may improve local control (LC) and overall survival (OS) in patients with borderline resectable (BRPC) and locally advanced pancreas cancer (LAPC). ....

United States , Baptist Health South Florida , Miami Cancer Institute , Health South , Pancreatic Cancer , Radiation Therapy , Clinical Trial , Proton Therapy ,

New breakthrough in pancreatic cancer research could help slow the disease's deadly spread

Scientists at Cold Spring Harbor Laboratory (CSHL) and the University of California, Davis have reached a new breakthrough in pancreatic cancer research-;eight years in the making. It could help slow the disease's deadly spread. ....

United States , David Tuveson , Christopher Vakoc , Cold Spring Harbor Laboratory , Scientists At Cold Spring Harbor Laboratory , University Of California , Spring Harbor , Chang Il Hwang , Pancreatic Cancer ,

Frontline Irinotecan Liposome OKed in Mets Pancreatic Cancer

The approval was based on improved overall and PFS with irinotecan liposome alongside oxaliplatin, fluorouracil, and leucovorin vs gemcitabine plus nab-paclitaxel. ....

Julie Fleshman , National Comprehensive Cancer Network , Pancreatic Cancer Action Network , Drug Administration , Ipsen Biopharmaceuticals Inc , Ipsen Biopharmaceuticals , Malignant Pancreatic Neoplasm , Pancreatic Cancer , Ancer Of The Pancreas , Alignant Neoplasia , Alignant Neoplasm , Pancreatic Adenocarcinoma , Denocarcinoma Of The Pancreas , Diarrhea Diarrhoea , Abdominal Pain , Pain Management , Us Food And Drug Administration , Nited States Food And Drug Administration ,

IPIAD augments standard therapy for pancreatic ductal adenocarcinoma

A new research perspective was published in Oncoscience (Volume 11) on February 7, 2024, entitled, "IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone." ....

Richarde Kast , Study Center ,

New mouse model illuminates lung cancer's transformation into aggressive variant

Lung tumors called adenocarcinomas sometimes respond to initially effective treatments by transforming into a much more aggressive small cell lung cancer (SCLC) that spreads rapidly and has few options for treatment. ....

Ethan Earlie , Ashley Laughney , Harold Varmus , Eric Gardner , Meyer Cancer Center At Weill Cornell Medicine , Lewis Thomas University Professor Of Medicine , Weill Cornell Medicine , Lewis Thomas University Professor , Edward Meyer Cancer Center , Weill Cornell , Meyer Cancer Center , Tri Institutional Computational Biology , Epidermal Growth Factor Receptor , Lung Cancer , Ouse Model , Small Cell Lung Cancer ,